In vitro screening for molecules that affect virus capsid assembly (and other protein association reactions)

Nature Protocols

Volumn 2, Issue 3, 2007, Pages 490-498

  Zlotnick, Adam ^a   Lee, Angela ^a   Bourne, Christina R ^a   Johnson, Jennifer M ^a   Domanico, Paul L ^b   Stray, Stephen J ^c  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ANTIVIRUS AGENT; CAPSID PROTEIN; CYSTEINE; FLUORESCENT DYE; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; DATA ANALYSIS; DRUG SCREENING; FLUORESCENCE ANALYSIS; HEPATITIS B VIRUS; IN VITRO STUDY; KINETICS; NONHUMAN; PIPETTE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STABILITY; PROTEIN TARGETING; THERMODYNAMICS; TIME; VIRION; VIROGENESIS; VIRUS CAPSID; BIOLOGICAL MODEL; DRUG EFFECT; FLUORESCENCE; METHODOLOGY; PHYSIOLOGY; VIRUS ASSEMBLY;

HEPATITIS B VIRUS; MIRIDAE;

ANTIVIRAL AGENTS; CAPSID; DRUG EVALUATION, PRECLINICAL; FLUORESCENCE; HEPATITIS B VIRUS; KINETICS; MODELS, BIOLOGICAL; VIRUS ASSEMBLY;

EID: 34347265820     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2007.60     Document Type: Article

References (42)

1. Alberts, B. et al. Molecular Biology of the Cell (Garland Publishing, New York, 1994).
2. Strausberg, R.L. & Schreiber, S.L. From knowing to controlling: A path from genomics to drugs using small molecule probes. Science 300 294-295 (2003).
3. Zlotnick, A. To build a virus capsid. An equilibrium model of the self assembly of polyhedral protein complexes. J. Mol. Biol. 241, 59-67 (1994).
4. Zlotnick, A., Ceres, P., Singh, S. & Johnson, J.M. A small molecule inhibits and misdirects assembly of hepatitis B virus capsids. J. Virol. 76, 4848-4854 (2002).
5. Prevelige, P.E.J. Inhibiting virus-capsid assembly by altering the polymerisation pathway. Trends Biotech. 16, 61-65 (1998).
6. Smith, T.J. et al. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science 233, 1286-1293 (1986).
7. Zhang, Y. et al. Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds. J. Virol. 78, 11061-11069 (2004).
8. Romero, J.R. Pleconaril: A novel antipicornaviral drug. Expert Opin. Investig. Drugs 10, 369-379 (2001).
9. Weber, O. et al. Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model. Antiviral Res. 54, 69-78 (2002).
10. Deres, K. et al. Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science 299, 893-896 (2003).
11. Hacker, H.J., Deres, K., Mildenberger, M. & Schroder, C.H. Antivirals interacting with hepatitis B virus core protein and core mutations may misdirect capsid assembly in a similar fashion. Biochem. Pharmacol. 66, 2273-2279 (2003).
12. Stray, S.J. et al. A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly. Proc. Natl. Acad. Sci. USA 102, 8138-8143 (2005).
13. Bourne, C., Finn, M.G. & Zlotnick, A. Global structural changes in hepatitis B capsids induced by the assembly effector HAP1. J. Virol. 80, 11055-11061 (2006).
14. Stray, S.J. & Zlotnick, A. BAY 41-4109 has multiple effects on hepatitis B virus capsid assembly. J. Mol. Recognit. 19, 542-548 (2006).
15. Stray, S.J., Johnson, J.M., Kopek, B.G. & Zlotnick, A. An in vitro fluorescence screen to identify antivirals that disrupt hepatitis B virus capsid assembly. Nat. Biotechnol. 24, 358-362 (2006).
16. Ganem, D. & Schneider, R.J. Hepadnaviridae: The Viruses and Their Replication. 4th edn. (Lippincott Williams & Wilkins, Philadelphia, 2001).
17. Zhou, S. & Standring, D.N. Hepatitis B virus capsid particles are assembled from core-protein dimer precursors. Proc. Natl. Acad. Sci. USA 89, 10046-10050 (1992).
18. Crowther, R.A. et al. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 77, 943-950 (1994).
19. Stannard, L.M. & Hodgkiss, M. Morphological irregularities in Dane particle cores. J. Gen. Virol. 45, 509-514 (1979).
20. Steven, A.C. et al. Structure, assembly, and antigenicity of hepatitis B virus capsid proteins. Adv. Virus Res. 64, 125-164 (2005).
21. Wynne, S.A., Crowther, R.A. & Leslie, A.G. The crystal structure of the human hepatitis B virus capsid. Mol. Cell 3, 771-780 (1999).
22. Dryden, K.A. et al. Native hepatitis B virions and capsids visualized by electron cryomicroscopy. Mol. Cell 22, 843-850 (2006).
23. Zlotnick, A., Johnson, J.M., Wingfield, P.W., Stahl, S.J. & Endres, D. A theoretical model successfully identifies features of hepatitis B virus capsid assembly. Biochemistry 38, 14644-14652 (1999).
24. Ceres, P. & Zlotnick, A. Weak protein-protein interactions are sufficient to drive assembly of hepatitis B virus capsids. Biochemistry 41, 11525-11531 (2002).
25. Zlotnick, A. Theoretical aspects of virus capsid assembly. J. Mol. Recognit. 18, 479-490 (2005).
26. Adolph, K.W. & Butler, P.J. Assembly of a spherical plant virus. Philos. Trans. R. Soc. Lond. B. 276, 113-122 (1976).
27. Prevelige, J., Thomas, D. & King, J. Scaffolding protein regulates the polymerization of P22 coat subunits into icosahedral shells in vitro. J. Mol. Biol. 202, 743-757 (1988).
28. Johnson, J.M. et al. Regulating self-assembly of spherical oligomers. Nano Lett. 5, 765-770 (2005).
29. Parent, K.N., Zlotnick, A. & Teschke, C.M. Quantitative analysis of multi-component spherical virus assembly: Scaffolding protein contributes to the global stability of phage P22 procapsids. J. Mol. Biol. 359, 1097-1106 (2006).
30. Rapaport, D.C. Self-assembly of polyhedral shells: A molecular dynamics study. Phys. Rev. E. 70, 051905 (2004).
31. Hagan, M.F. & Chandler, D. Dynamic pathways for viral capsid assembly. Biophys. J. (2006).
32. Zhang, T. & Schwartz, R. Simulation study of the contribution of oligomer/oligomer binding to capsid assembly kinetics. Biophys. J. 90, 57-64 (2006).
33. Reddy, V.S. et al. Virus Particle Explorer (VIPER), a website for virus capsid structures and their computational analyses. J. Virol. 75, 11943-11947 (2001).
34. Riddles, P.W., Blakeley, R.L. & Zerner, B. Reassessment of Ellman's reagent. Methods Enzymol. 91, 49-60 (1983).
35. Bergstrom, F. et al. Dimers of dipyrrometheneboron difluoride (BODIPY) with light spectroscopic applications in chemistry and biology. J. Am. Chem. Soc. 124, 196-204 (2002).
36. Vogel, M., Diez, M., Eisfeld, J. & Nassal, M. In vitro assembly of mosaic hepatitis B virus capsid-like particles (CLPs): Rescue into CLPs of assembly-deficient core protein fusions and FRET-suited CLPs. FEBS Lett. 579, 5211-5216 (2005).
37. Endres, D., Miyahara, M., Moisant, P. & Zlotnick, A. A reaction landscape identifies the intermediates critical for self-assembly of virus capsids and other polyhedral structures. Protein Sci. 14 1518-1525 (2005).
38. van Holde, K.E., Johnson, W.C. & Ho, P.S. Principles of Physical Biochemistry. (Prentice-Hall, Upper Saddle River, New Jersey, 1998).
39. Pace, C.N., Vajdos, F., Fee, L., Grimsley, G. & Gray, T. How to measure and predict the molar absorption coefficient of a protein. Protein Sci. 4, 2411-2423 (1995).
40. Stray, S.J., Ceres, P. & Zlotnick, A. Zinc ions trigger conformational change and oligomerization of hepatitis B virus capsid protein. Biochemistry 43, 9989-9998 (2004).
41. Lakowicz, J.R. Principles of Fluorescence Spectroscopy. 2nd edn. (Kluwer Academic/Plenum Publishers, New York, 1999).
42. Ceres, P., Stray, S.J. & Zlotnick, A. Hepatitis B virus capsid assembly is enhanced by naturally occurring mutation F97L. J. Virol. 78 9538-9543 (2004).